NASDAQ: PMVPPmv Pharmaceuticals Inc Stock Ownership - Who owns Pmv Pharmaceuticals?
Insider buying vs selling
Have Pmv Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| David Henry MacK | President and CEO | 2025-10-27 | 220,643 | $1.37 | $302.28kBuy |
| Orbimed Advisors LLC | 10% Owner | 2025-10-23 | 1,000,000 | $1.52 | $1.52MSell |
| Orbimed Advisors LLC | 10% Owner | 2025-09-10 | 500,000 | $1.80 | $900.00kSell |
| Deepika Jalota | Chief Development Officer | 2025-07-01 | 33,065 | $1.07 | $35.21kSell |
| David Henry MacK | President and CEO | 2025-07-01 | 58,411 | $1.07 | $62.21kSell |
| Michael Carulli | Chief Financial Officer | 2025-07-01 | 28,249 | $1.07 | $30.09kSell |
| Robert Ticktin | General Counsel COO | 2025-07-01 | 23,151 | $1.07 | $24.66kSell |
PMVP insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when PMVP insiders and whales buy or sell their stock.
PMVP Shareholders
What type of owners hold Pmv Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Arnold L. Oronsky | 12.13% | 6,469,911 | $8.35M | Insider |
| Bml Capital Management LLC | 9.98% | 5,320,000 | $6.86M | Institution |
| Orbimed Advisors LLC | 9.54% | 5,089,330 | $6.57M | Insider |
| Interwest Partners X LP | 8.44% | 4,502,480 | $5.81M | Insider |
| Tang Capital Management LLC | 7.96% | 4,245,085 | $5.48M | Institution |
| Sio Capital Management LLC | 5.77% | 3,076,580 | $3.97M | Institution |
| Arrowmark Colorado Holdings LLC | 5.39% | 2,872,764 | $3.71M | Institution |
| Euclidean Capital LLC | 4.93% | 2,627,643 | $3.39M | Institution |
| V. Oncology Scs Sicavsif Nextech | 4.74% | 2,528,290 | $3.26M | Insider |
| Eversept Partners LP | 4.40% | 2,348,360 | $3.03M | Institution |
PMVP vs Biotech Stocks
Pmv Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.